Indication
Life-threatening ventricular tachycardia
Life-threatening ventricular tachycardia is a high-acuity cardiovascular arrhythmia originating within the ventricular myocardium or His-Purkinje conduction system. Read more about Life-threatening ventricular tachycardia
144 drugs 82 manufacturers
Drugs that treat it
Common Life-threatening ventricular tachycardia therapies.
FLECAINIDE ACETATE
FLECAINIDE ACETATE
FLECAINIDE ACETATE
SOTALOL HCL
FLECAINIDE ACETATE
AMIODARONE HCL
PROPRANOLOL HCL
AMIODARONE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLife-threatening ventricular tachycardia is a high-acuity cardiovascular arrhythmia originating within the ventricular myocardium or His-Purkinje conduction system.
It is pathologically characterized by three or more consecutive premature ventricular depolarizations at rates typically exceeding 100 beats per minute, commonly driven by myocardial reentry circuits, abnormal automaticity, or triggered activity related to structural heart disease or ischemic scarring.
The rapid rate critically compromises ventricular filling, stroke volume, and systemic perfusion, manifesting as profound hemodynamic instability, syncope, hypotension, or acute cardiogenic collapse.
Primarily affecting patients with ischemic cardiomyopathy, structural heart abnormalities, or cardiac channelopathies, this clinical state carries an immediate risk of precipitating cardiac arrest and sudden cardiac death via degeneration into ventricular fibrillation.
- nih.gov
Life-threatening ventricular tachycardia is a high-acuity cardiovascular arrhythmia originating within the ventricular myocardium or His-Purkinje conduction system
- nih.gov
Life-threatening ventricular tachycardia is a high-acuity cardiovascular arrhythmia originating within the ventricular myocardium or His-Purkinje conduction system It is pathologically characterized by three or more consecutive premature ventricular depolarizations at rates typically exceeding 100 beats per minute, commonly driven by myocardial reentry circuits, abnormal automaticity, or triggered activity related to structural heart disease or ischemic scarring
- nih.gov
It is pathologically characterized by three or more consecutive premature ventricular depolarizations at rates typically exceeding 100 beats per minute, commonly driven by myocardial reentry circuits, abnormal automaticity, or triggered activity related to structural heart disease or ischemic scarring The rapid rate critically compromises ventricular filling, stroke volume, and systemic perfusion, manifesting as profound hemodynamic instability, syncope, hypotension, or acute cardiogenic collaps...
- mayoclinic.org
The rapid rate critically compromises ventricular filling, stroke volume, and systemic perfusion, manifesting as profound hemodynamic instability, syncope, hypotension, or acute cardiogenic collapse
- nih.gov
Primarily affecting patients with ischemic cardiomyopathy, structural heart abnormalities, or cardiac channelopathies, this clinical state carries an immediate risk of precipitating cardiac arrest and sudden cardiac death via degeneration into ventricular fibrillation
- wakemed.org
Primarily affecting patients with ischemic cardiomyopathy, structural heart abnormalities, or cardiac channelopathies, this clinical state carries an immediate risk of precipitating cardiac arrest and sudden cardiac death via degeneration into ventricular fibrillation
Personalize your experience
Follow Life-threatening ventricular tachycardia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.